SS-31 Chemistry: Cardiolipin-Targeting Tetrapeptide
A bench-level reference sheet on SS-31, also called elamipretide: a small cell-permeable tetrapeptide whose alternating aromatic-cationic motif drives its affinity for cardiolipin, how the sequence is assembled, and what to read off it before keeping one as a research reference standard.
Sequence and Structure
SS-31 is a cell-permeable tetrapeptide, a four-residue chain that is short even by the standards of research peptides. What makes it distinctive is not its length but its pattern: the residues alternate between aromatic side chains and cationic, basic side chains. That alternating aromatic-cationic motif is the defining structural feature of the SS series, and it is the lens through which the rest of the chemistry is best read.
Because two of the four positions carry basic side chains, the peptide holds a net positive charge at physiological pH, while the aromatic positions contribute flat, hydrophobic surface. The result is a small molecule that is both water-soluble and able to cross lipid membranes without a transporter, which is why it is described as cell-permeable. For a research chemist the practical takeaway is that almost everything that follows, from solubility to membrane affinity to handling, traces back to this compact charge-and-ring arrangement.
Origin and Family: The SS Peptides
SS-31, also known as elamipretide, belongs to the small family of Szeto-Schiller (SS) peptides, a set of aromatic-cationic tetrapeptides designed around the same alternating motif. Within that family SS-31 is the most widely studied member and the one most often held as a reference standard. Its second common name, elamipretide, is the one used in much of the formal literature, so the two labels point to the same molecule.
What sets this family apart from most research peptides is that it is mitochondria-associated rather than receptor-associated. Instead of binding a cell-surface receptor, SS-31 selectively associates with cardiolipin, an anionic phospholipid concentrated in the inner mitochondrial membrane. That single binding preference is the throughline of the whole SS series, and it is why these peptides are grouped under the mitochondrial class in the catalog alongside compounds such as NAD+.
Why Fmoc Synthesis Suits a Cationic Tetrapeptide
At four residues, SS-31 is well within the comfortable range for Fmoc solid-phase peptide synthesis. Short chains assemble in a single linear sequence with no need for fragment ligation, and the base-labile Fmoc protecting strategy with mild acidic cleavage keeps the aromatic and basic side chains intact through the build. For a peptide this size, the chemistry is routine rather than demanding.
The points that need care are the cationic positions. Basic side chains require side-chain protection that is removed cleanly at cleavage, and the strong positive charge influences how the crude peptide behaves during purification. Because the sequence is so short, coupling efficiency is rarely the limiting factor; the work is mostly in clean deprotection and in a purification step that resolves the target from closely related sequences. The same general approach is used across the catalog for compact peptides such as the Epitalon tetrapeptide.
Characterization
Identity and purity for SS-31 are established with the same two complementary methods used across the reference catalog. Reversed-phase HPLC reports the purity profile, the percentage of total peak area attributable to the target peptide, and separates the main product from related deletion or truncation sequences. Mass spectrometry confirms identity by matching the measured mass to the expected mass for the tetrapeptide sequence.
Reading these together is what matters. An HPLC purity figure describes how much of the sample is the intended peptide relative to other UV-absorbing species, while the mass result confirms that the main peak is the right molecule rather than a same-length impurity. For an aromatic-cationic peptide the aromatic residues give a strong UV signal that makes the HPLC trace easy to read, which is a small but real convenience when interpreting a method. Both pieces of information describe the chemistry of the sequence, and a research chemist should expect to interpret them side by side.
Stability and Storage
As a lyophilized powder, SS-31 is comparatively stable when kept cold, dry, and out of light. Long-term storage of the dry solid is typically at freezer temperatures, with the container protected from moisture so the powder does not pick up water on opening. Allowing a sealed vial to reach room temperature before it is opened helps avoid condensation on the cold contents, which is good practice for any small hygroscopic peptide.
Once reconstituted, the working solution is less forgiving. Peptides in solution are subject to hydrolysis and adsorption to surfaces, so reconstituted material is generally held cold and used within a short window, with freeze-thaw cycles minimized. These are general handling principles for research peptides rather than claims about any one preparation, and the documentation for a given standard, available on request, should be the reference of record for its own conditions.
What SS-31 Is Studied For (Chemistry Only)
In a research-chemistry context, SS-31 is of interest as a clean model system for studying how a peptide targets a specific lipid rather than a protein receptor. Its alternating aromatic-cationic design makes it a compact case study in structure-activity work: chemists can examine how charge placement and aromatic content govern membrane permeability and selective binding to cardiolipin, the inner-mitochondrial-membrane phospholipid the SS peptides are known to associate with.
That framing is deliberately limited to the bench. These materials are reference standards for laboratory research only, and nothing here describes or implies any human or veterinary use or outcome. The value of SS-31 to a research chemist is as a chemistry subject, a small well-defined sequence whose behavior under synthesis, analysis, and storage is understood and worth knowing in detail. For broader context on how these standards are produced and verified, see the Research Overviews hub.
This overview is provided for laboratory and research use only. It is educational chemistry reference material and is not for human or veterinary consumption. Buyers are responsible for compliance with all applicable laws and regulations.
SS-31, in brief
What is SS-31 and what does its sequence look like?
SS-31, also known as elamipretide, is a cell-permeable tetrapeptide built on an alternating aromatic-cationic motif. Its four residues pair basic side chains with aromatic rings, which is the structural feature behind both its solubility and its affinity for cardiolipin. It is a small, linear sequence assembled by standard solid-phase methods.
Why does SS-31 bind cardiolipin and concentrate in mitochondria?
The alternating aromatic-cationic design gives SS-31 a net positive charge alongside aromatic surface, so it associates with the anionic phospholipid cardiolipin that is enriched in the inner mitochondrial membrane. That selective binding is why the peptide is described as mitochondria-targeting in the research literature, and it is studied purely as a chemistry and structure-activity question.
How is SS-31 synthesized and characterized?
SS-31 is assembled by Fmoc solid-phase peptide synthesis, which suits a short cationic tetrapeptide. Identity and purity are confirmed using reversed-phase HPLC for the purity profile and mass spectrometry to match the measured mass to the expected sequence. These are standard analytical methods used across the reference catalog.
How should SS-31 be stored?
As a lyophilized powder, SS-31 is kept cold, dry, and out of light, with the dry solid typically held at freezer temperatures and protected from moisture. Once reconstituted it is held cold, used within a short window, and freeze-thaw cycles are minimized. These are general handling principles for research peptides.